1,059
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age

, , , , , , , , , , , , , , , , , , , , & show all
Pages 362-380 | Received 26 Mar 2010, Accepted 20 Apr 2010, Published online: 09 Jul 2010

References

  • Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159–163.
  • Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med 2009;22:633–635.
  • Romero R. Prenatal medicine: the child is the father of the man. 1996. J Matern Fetal Neonatal Med 2009;22:636–639.
  • Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 1994;399:64–70.
  • Hokken-Koelega AC, de Ridder MA, Lemmen RJ, Den HH, De Muinck Keizer-Schrama SM, Drop SL. Children born small for gestational age: do they catch up? Pediatr Res 1995;38:267–271.
  • Gazzolo D, Scopesi FA, Bruschettini PL, Marasini M, Esposito V, Di Renzo GC, de Toni E. Predictors of perinatal outcome in intrauterine growth retardation: a long term study. J Perinat Med 1994;22:71–77.
  • Padoan A, Rigano S, Ferrazzi E, Beaty BL, Battaglia FC, Galan HL. Differences in fat and lean mass proportions in normal and growth-restricted fetuses. Am J Obstet Gynecol 2004;191:1459–1464.
  • Verkauskiene R, Figueras F, Deghmoun S, Chevenne D, Gardosi J, Levy-Marchal M. Birth weight and long-term metabolic outcomes: does the definition of smallness matter? Horm Res 2008;70:309–315.
  • Berko P, Joubert K. The effect of intrauterine development and nutritional status on perinatal mortality. J Matern Fetal Neonatal Med 2009;22:552–559.
  • Hayes B, Sharif F. Behavioural and emotional outcome of very low birth weight infants – literature review. J Matern Fetal Neonatal Med 2009;22:849–856.
  • Puddu M, Podda MF, Mussap M, Tumbarello R, Fanos V. Early detection of microalbuminuria and hypertension in children of very low birthweight. J Matern Fetal Neonatal Med 2009;22:83–88.
  • Tome T, Guimaraes H, Bettencourt A, Peixoto JC. Neonatal morbi-mortality in very low birth weight in Europe: the Portuguese experience. J Matern Fetal Neonatal Med 2009;22(Suppl 3):85–87.
  • Hackman E, Emanuel I, van BG, Daling J. Maternal birth weight and subsequent pregnancy outcome. JAMA 1983;250:2016–2019.
  • Lang JM, Cohen A, Lieberman E. Risk factors for small-for-gestational-age birth in a preterm population. Am J Obstet Gynecol 1992;166:1374–1378.
  • Magnus P, Bakketeig LS, Skjaerven R. Correlations of birth weight and gestational age across generations. Ann Hum Biol 1993;20:231–238.
  • Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994;171:410–416.
  • Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, Paul RH. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The national institute of child health and human development network of maternal-fetal medicine units. Am J Obstet Gynecol 1995;172:642–648.
  • Meis PJ, Michielutte R, Peters TJ, Wells HB, Sands RE, Coles EC, Johns KA. Factors associated with preterm birth in Cardiff, Wales. II. Indicated and spontaneous preterm birth. Am J Obstet Gynecol 1995;173:597–602.
  • Savitz DA, Olshan AF, Gallagher K. Maternal occupation and pregnancy outcome. Epidemiology 1996;7:269–274.
  • Goldenberg RL, Cliver SP. Small for gestational age and intrauterine growth restriction: definitions and standards. Clini Obstet Gynecol 1997;40:704–714.
  • Kramer MS, Platt R, Yang H, McNamara H, Usher RH. Are all growth-restricted newborns created equal(ly)? Pediatrics 1999;103:599–602.
  • Yang J, Savitz DA. The effect of vaginal bleeding during pregnancy on preterm and small-for-gestational-age births: US National Maternal and Infant Health Survey, 1988. Paediatr Perinat Epidemiol 2001;15:34–39.
  • Spinillo A, Bergante C, Gardella B, Mainini R, Montanari L. Interaction between risk factors for fetal growth retardation associated with abnormal umbilical artery Doppler studies. Acta Obstet Gynecol Scand 2004;83:431–435.
  • Allen VM, Joseph K, Murphy KE, Magee LA, Ohlsson A. The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population based study. BMC Preg Childbirth 2004;4:17.
  • Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004;104:727–733.
  • Savitz DA, Kaufman JS, Dole N, Siega-Riz AM, Thorp JM, Jr., Kaczor DT. Poverty, education, race, and pregnancy outcome. Ethn Dis 2004;14:322–329.
  • Jaquet D, Swaminathan S, Alexander GR, Czernichow P, Collin D, Salihu HM, Kirby RS, Levy-Marchal C. Significant paternal contribution to the risk of small for gestational age. BJOG 2005;112:153–159.
  • Kleijer ME, Dekker GA, Heard AR. Risk factors for intrauterine growth restriction in a socio-economically disadvantaged region. J Matern Fetal Neonatal Med 2005;18:23–30.
  • Odibo AO, Nelson D, Stamilio DM, Sehdev HM, Macones GA. Advanced maternal age is an independent risk factor for intrauterine growth restriction. Am J Perinatol 2006;23:325–328.
  • Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. Chronic hypertension as a risk factor for offspring to be born small for gestational age. Acta Obstet Gynecol Scand 2006;85:1046–1050.
  • Fantuzzi G, Vaccaro V, Aggazzotti G, Righi E, Kanitz S, Barbone F, Sansebastiano G, Battaglia MA, Leoni V, et al Exposure to active and passive smoking during pregnancy and severe small for gestational age at term. J Matern Fetal Neonatal Med 2008;21:643–647.
  • Bruno CJ, Locke R, Mackley A, Paul DA. The association between maternal body mass index and severity of neonatal illness in very low birth weight infants. J Matern Fetal Neonatal Med 2009;22:560–564.
  • Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977;84:656–663.
  • De Wolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980;87:678–685.
  • Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049–1059.
  • Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002;187:1416–1423.
  • Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981;88:695–705.
  • Campbell S, Diaz-Recasens J, Griffin DR, Cohen-Overbeek TE, Pearce JM, Willson K, Teague MJ. New doppler technique for assessing uteroplacental blood flow. Lancet 1983;1:675–677.
  • Harrington KF, Campbell S, Bewley S, Bower S. Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. Eur J Obstet Gynecol Reprod Biol 1991;42(Suppl):S14–S20.
  • Bower S, Schuchter K, Campbell S. Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1993;100:989–994.
  • Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996;7:182–188.
  • Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G. Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 1999;20:389–394.
  • Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559–564.
  • Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441–449.
  • Ferrazzi E, Bellotti M, Galan H, Pennati G, Bozzo M, Rigano S, Battaglia FC. Doppler investigation in intrauterine growth restriction – from qualitative indices to flow measurements: a review of the experience of a collaborative group. Ann NY Acad Sci 2001;943:316–325.
  • Rigano S, Bozzo M, Ferrazzi E, Bellotti M, Battaglia FC, Galan HL. Early and persistent reduction in umbilical vein blood flow in the growth-restricted fetus: a longitudinal study. Am J Obstet Gynecol 2001;185:834–838.
  • Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004;18:383–396.
  • Bretelle F, Sabatier F, Blann A, D'Ercole C, Boutiere B, Mutin M, Boubli L, Sampol J, Dignat-George F. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia. BJOG 2001;108:1277–1282.
  • Coata G, Pennacchi L, Bini V, Liotta L, Di Renzo GC. Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction. J Matern Fetal Neonatal Med 2002;12:28–34.
  • Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ. Does endothelial cell activation occur with intrauterine growth restriction? BJOG 2002;109:836–839.
  • Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195:40–49.
  • Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158–166.
  • Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996;106:127–133.
  • Hahn-Zoric M, Hagberg H, Kjellmer I, Ellis J, Wennergren M, Hanson LA. Aberrations in placental cytokine mRNA related to intrauterine growth retardation. Pediatr Res 2002;51:201–206.
  • Bartha JL, Romero-Carmona R, Comino-Delgado R. Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand 2003;82:1099–1102.
  • Kusanovic JP, Romero R, Hassan SS, Gotsch F, Edwin S, Chaiworapongsa T, Erez O, Mittal P, Mazaki-Tovi S, Soto E, et al Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med 2007;20:867–878.
  • Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770–775.
  • Malamitsi-Puchner A, Boutsikou T, Economou E, Sarandakou A, Makrakis E, Hassiakos D, Creatsas G. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Mediators Inflamm 2005;2005:293–297.
  • Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005;90:4895–4903.
  • Boutsikou T, Malamitsi-Puchner A, Economou E, Boutsikou M, Puchner KP, Hassiakos D. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev 2006;82:235–239.
  • Crispi F, Dominguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006;195:201–207.
  • Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006;203:2165–2175.
  • Padavala S, Pope N, Baker P, Crocker I. An imbalance between vascular endothelial growth factor and its soluble receptor in placental villous explants of intrauterine growth-restricted pregnancies. J Soc Gynecol Investig 2006;13:40–47.
  • Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol 2006;195:1668–1673.
  • Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) 2007;112:51–57.
  • Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, Edwin S, Kusanovic JP, Erez O, Than NG, et al The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med 2008;21:25–40.
  • Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:303–309.
  • Di Renzo GC. The role of an ‘anti-angiogenic state’ in complications of pregnancy. J Matern Fetal Neonatal Med 2008;21:3–7.
  • Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, et al The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008;21:279–287.
  • Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsh F, Erez O, Mazaki-Tovi S, et al A longitudinal study of angiogenic (placental growth factor) and anti angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate. J Matern Fetal Neonatal Med 2008;21:9–23.
  • Gotsch F, Romero R, Kusanovic JP, Chaiworapongsa T, Dombrowski M, Erez O, Than NG, Mazaki-Tovi S, Mittal P, Espinoza J, et al Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med 2008;21:389–402.
  • Toft JH, Lian IA, Tarca AL, Erez O, Espinoza J, Eide IP, Bjorge L, Draghici S, Romero R, Austgulen R. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies. J Matern Fetal Neonatal Med 2008;21:267–273.
  • Chaiworapongsa T, Romero R, Gotsch F, Espinoza J, Nien JK, Goncalves L, Edwin S, Kim YM, Erez O, Kusanovic JP, et al Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med 2008;21:41–52.
  • Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008;28:1110–1115.
  • Ounsted M, Ounsted C. Rate of intra-uterine growth. Nature 1968;220:599–600.
  • Klebanoff MA, Graubard BI, Kessel SS, Berendes HW. Low birth weight across generations. JAMA 1984;252:2423–2427.
  • Klebanoff MA, Schulsinger C, Mednick BR, Secher NJ. Preterm and small-for-gestational-age birth across generations. Am J Obstet Gynecol 1997;176:521–526.
  • Winkvist A, Mogren I, Hogberg U. Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 1998;27:248–254.
  • Wang X, Zuckerman B, Coffman GA, Corwin MJ. Familial aggregation of low birth weight among whites and blacks in the United States. N Engl J Med 1995;333:1744–1749.
  • La Batide-Alanore A, Tregouet DA, Jaquet D, Bouyer J, Tiret L. Familial aggregation of fetal growth restriction in a French cohort of 7,822 term births between 1971 and 1985. Am J Epidemiol 2002;156:180–187.
  • Thompson JM, Clark PM, Robinson E, Becroft DM, Pattison NS, Glavish N, Pryor JE, Wild CJ, Rees K, Mitchell EA. Risk factors for small-for-gestational-age babies: the Auckland birthweight collaborative study. J Paediatr Child Health 2001;37:369–375.
  • Alexander GR, Wingate MS, Mor J, Boulet S. Birth outcomes of Asian–Indian–Americans. Int J Gynaecol Obstet 2007;97:215–220.
  • Jaquet D, Tregouet DA, Godefroy T, Nicaud V, Chevenne D, Tiret L, Czernichow P, Levy-Marchal C. Combined effects of genetic and environmental factors on insulin resistance associated with reduced fetal growth. Diabetes 2002;51:3473–3478.
  • Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287:195–202.
  • Johnston LB, Dahlgren J, Leger J, Gelander L, Savage MO, Czernichow P, Wikland KA, Clark AJ. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab 2003;88:4805–4810.
  • Akisu M, Balim Z, Cetin H, Kosova B, Yalaz M, Topcuoglu N, Kultursay N. The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intrauterine growth restriction. Early Hum Dev 2004;78:95–103.
  • Infante-Rivard C. Drinking water contaminants, gene polymorphisms, and fetal growth. Environ Health Perspect 2004;112:1213–1216.
  • Verspyck E, Borg JY, Le Cam-Duchez V, Goffinet F, Degre S, Fournet P, Marpeau L. Thrombophilia and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2004;113:36–40.
  • Yamada H, Sata F, Kato EH, Saijo Y, Kataoka S, Morikawa M, Shimada S, Yamada T, Kishi R, Minakami H. A polymorphism in the CYP17 gene and intrauterine fetal growth restriction. Mol Hum Reprod 2004;10:49–53.
  • Adkins RM, Campese C, Vaidya R, Boyd TK. Association between fetal growth restriction and polymorphisms at sites −1 and +3 of pituitary growth hormone: a case–control study. BMC Pregn Childbirth 2005;5:2.
  • Engel SA, Olshan AF, Savitz DA, Thorp J, Erichsen HC, Chanock SJ. Risk of small-for-gestational age is associated with common anti-inflammatory cytokine polymorphisms. Epidemiology 2005;16:478–486.
  • Sziller I, Nguyen D, Halmos A, Hupuczi P, Papp Z, Witkin SS. An A > G polymorphism at position -670 in the Fas (TNFRSF6) gene in pregnant women with pre-eclampsia and intrauterine growth restriction. Mol Hum Reprod 2005;11:207–210.
  • Engel SM, Olshan AF, Siega-Riz AM, Savitz DA, Chanock SJ. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth. Am J Obstet Gynecol 2006;195:1231.e1–11.
  • Casano-Sancho P, Lopez-Bermejo A, Fernandez-Real JM, Monros E, Valls C, Rodriguez-Gonzalez FX, Ricart W, Ibanez L. The tumour necrosis factor (TNF)-α- 308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance. Clin Endocrinol (Oxf) 2006;64:129–135.
  • Gibson CS, MacLennan AH, Janssen NG, Kist WJ, Hague WM, Haan EA, Goldwater PN, Priest K, Dekker GA. Associations between fetal inherited thrombophilia and adverse pregnancy outcomes. Am J Obstet Gynecol 2006;194:947.e1–10.
  • Sata F, Yamada H, Suzuki K, Saijo Y, Yamada T, Minakami H, Kishi R. Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction. Pharmacogenet Genomics 2006;16:775–781.
  • Infante-Rivard C, Weinberg CR, Guiguet M. Xenobiotic-metabolizing genes and small-for-gestational-age births: interaction with maternal smoking. Epidemiology 2006;17:38–46.
  • Dissanayake VH, Tower C, Broderick A, Stocker LJ, Seneviratne HR, Jayasekara RW, Kalsheker N, Broughton PF, Morgan L. Polymorphism in the epidermal growth factor gene is associated with birthweight in Sinhalese and white Western Europeans. Mol Hum Reprod 2007;13:425–429.
  • Gremlich S, Nguyen D, Reymondin D, Hohlfeld P, Vial Y, Witkin SS, Gerber S. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. J Reprod Immunol 2007;74:143–151.
  • Polydorides AD, Kalish RB, Witkin SS, Baergen RN. A fetal cyclooxygenase-2 gene polymorphism is associated with placental malperfusion. Int J Gynecol Pathol 2007;26:284–290.
  • Sziller I, Babula O, Hupuczi P, Nagy B, Rigo B, Szabo G, Papp Z, Linhares IM, Witkin SS. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction. Mol Hum Reprod 2007;13:281–285.
  • Adkins RM, Krushkal J, Klauser CK, Magann EF, Morrison JC, Somes G. Association between small for gestational age and paternally inherited 5′ insulin haplotypes. Int J Obes (Lond) 2008;32:372–380.
  • Delpisheh A, Topping J, Reyad M, Tang A, Brabin BJ. Prenatal alcohol exposure, CYP17 gene polymorphisms and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2008;138:49–53.
  • Furness DL, Fenech MF, Khong YT, Romero R, Dekker GA. One-carbon metabolism enzyme polymorphisms and uteroplacental insufficiency. Am J Obstet Gynecol 2008;199:276–278.
  • Delpisheh A, Brabin L, Topping J, Reyad M, Tang AW, Brabin BJ. A case–control study of CYP1A1, GSTT1 and GSTM1 gene polymorphisms, pregnancy smoking and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2009;143:38–42.
  • Aagaard-Tillery K, Spong CY, Thom E, Sibai B, Wendel G, Jr., Wenstrom K, Samuels P, Simhan H, Sorokin Y, Miodovnik M, et al Pharmacogenomics of maternal tobacco use: metabolic gene polymorphisms and risk of adverse pregnancy outcomes. Obstet Gynecol 2010;115:568–577.
  • Bodnar LM, Catov JM, Zmuda JM, Cooper ME, Parrott MS, Roberts JM, Marazita ML, Simhan HN. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr 2010;140:999–1006.
  • Nagaya K, Makita Y, Taketazu G, Okamoto T, Nakamura E, Hayashi T, Fujieda K. Paternal allele of IGF2 gene haplotype CTG is associated with fetal and placental growth in Japanese. Pediatr Res 2009;66:135–139.
  • Gonzalez RP, Gomez RM, Castro RS, Nien JK, Merino PO, Etchegaray AB, Carstens MR, Medina LH, Viviani PG, Rojas IT. [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. Rev Med Chil 2004;132:1155–1165.
  • Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, et al Haplotype variation and linkage disequilibrium in 313 human genes. Science 2001;293:489–493.
  • Judson R, Salisbury B, Schneider J, Windemuth A, Stephens JC. How many SNPs does a genome-wide haplotype map require? Pharmacogenomics 2002;3:379–391.
  • Kuivaniemi H, Yoon S, Shibamura H, Skunca M, Vongpunsawad S, Tromp G. Primer-extension preamplified DNA is a reliable template for genotyping. Clin Chem 2002;48:1601–1604.
  • Winkelmann BR, Hoffmann MM, Nauck M, Kumar AM, Nandabalan K, Judson RS, Boehm BO, Tall AR, Ruano G, Marz W. Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy. Pharmacogenomics J 2003;3:284–296.
  • Boehnke M, Cox NJ. Accurate inference of relationships in sib-pair linkage studies. Am J Hum Genet 1997;61:423–429.
  • Goring HH, Ott J. Relationship estimation in affected sib pair analysis of late-onset diseases. Eur J Hum Genet 1997;5:69–77.
  • Olson JM. Relationship estimation by Markov-process models in a sib-pair linkage study. Am J Hum Genet 1999;64:1464–1472.
  • Epstein MP, Duren WL, Boehnke M. Improved inference of relationship for pairs of individuals. Am J Hum Genet 2000;67:1219–1231.
  • Abecasis GR, Cherny SS, Cookson WO, Cardon LR. GRR: graphical representation of relationship errors. Bioinformatics 2001;17:742–743.
  • Douglas JA, Skol AD, Boehnke M. Probability of detection of genotyping errors and mutations as inheritance inconsistencies in nuclear-family data. Am J Hum Genet 2002;70:487–495.
  • Lee WC. Detecting population stratification using a panel of single nucleotide polymorphisms. Int J Epidemiol 2003;32:1120.
  • Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Jr., Ellis MC, Fullan A, et al A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399–408.
  • Nielsen DM, Ehm MG, Weir BS. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 1998;63:1531–1540.
  • Wittke-Thompson JK, Pluzhnikov A, Cox NJ. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:967–986.
  • Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 2006;163:300–309.
  • Ryckman KK, Jiang L, Li C, Bartlett J, Haines JL, Williams SM. A prevalence-based association test for case–control studies. Genet Epidemiol 2008;32:600–605.
  • Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155:945–959.
  • Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–575.
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1995;57:289–300.
  • Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279–284.
  • Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995;29:311–322.
  • Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263–265.
  • Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al The structure of haplotype blocks in the human genome. Science 2002;296:2225–2229.
  • Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138–147.
  • Velez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, Williams SM, Moore JH. A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol 2007;31:306–315.
  • Moore JH, White BC. Tuning ReliefF for Genome-Wide Genetic Analysis. In: Marchiori E, Moore JH, Rajapakse JC, editors. Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics. Heidelberg: Springer Berlin; 2007. pp. 166–175.
  • Kira K, Rendell LA. A Practical Approach to Feature Selection. In: Sleeman D, Edwards P, editors. Proceedings of the Ninth International Workshop on Machine Learning. Aberdeen: Morgan-Kaufman; 1992; pp. 249–256.
  • Greene CS, Penrod NM, Kiralis J, Moore JH. Spatially uniform reliefF (SURF) for computationally-efficient filtering of gene–gene interactions. Bio Data Min 2009;2:5.
  • Moore JH, Asselbergs FW, Williams SM. Bioinformatics challenges for genome-wide association studies. Bioinformatics 2010;26:445–455.
  • Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, et al A network-based analysis of systemic inflammation in humans. Nature 2005;437:1032–1037.
  • Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, Egan DA, Ketema M, van den NR, van den Eeden SJ, Geluk A, et al Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 2007;450:725–730.
  • Loza MJ, McCall CE, Li L, Isaacs WB, Xu J, Chang BL. Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS One 2007;2:e1035.
  • Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S, Pereira L, et al Gene expression profiling of the human maternal–fetal interface reveals dramatic changes between midgestation and term. Endocrinology 2007;148:1059–1079.
  • Menon R, Pearce B, Velez DR, Merialdi M, Williams SM, Fortunato SJ, Thorsen P. Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod Biol Endocrinol 2009;7:62.
  • Dunn PA, Feinberg RF. Oncofetal fibronectin: new insight into the physiology of implantation and labor. J Obstet Gynecol Neonatal Nurs 1996;25:753–757.
  • Koenn ME. Fetal fibronectin. Clin Lab Sci 2002;15:96–98, 115.
  • Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Fetal fibronectin levels are elevated in maternal plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1995;172:649–653.
  • Sakura M, Nakabayashi M, Takeda Y, Sato K. Elevated fetal fibronectin in midtrimester amniotic fluid is involved with the onset of preeclampsia. J Obstet Gynaecol Res 1998;24:73–76.
  • Williams CM, Engler AJ, Slone RD, Galante LL, Schwarzbauer JE. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res 2008;68:3185–3192.
  • Vadillo-Ortega F, Gonzalez-Avila G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss JF, III. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995;146:148–156.
  • Vadillo OF, Arechevaleta F, Beltran MJ. [Apoptosis and extracellular matrix degradation in chorio-amnion during labor and premature membrane rupture]. Ginecol Obstet Mex 1998;66:202–207.
  • Athayde N, Romero R, Gomez R, Maymon E, Pacora P, Mazor M, Yoon BH, Fortunato S, Menon R, Ghezzi F, et al Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med 1999;8:213–219.
  • Maymon E, Romero R, Pacora P, Gervasi MT, Gomez R, Edwin SS, Yoon BH. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 2000;183:887–894.
  • Arechavaleta-Velasco F, Mayon-Gonzalez J, Gonzalez-Jimenez M, Hernandez-Guerrero C, Vadillo-Ortega F. Association of type II apoptosis and 92-kDa type IV collagenase expression in human amniochorion in prematurely ruptured membranes with tumor necrosis factor receptor-1 expression. J Soc Gynecol Investig 2002;9:60–67.
  • Romero R, Chaiworapongsa T, Espinoza J, Gomez R, Yoon BH, Edwin S, Mazor M, Maymon E, Berry S. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol 2002;187:1125–1130.
  • Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 2002;87:1353–1361.
  • Goldman S, Weiss A, Eyali V, Shalev E. Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Mol Hum Reprod 2003;9:367–373.
  • Makrakis E, Grigoriou O, Kouskouni E, Vitoratos N, Salamalekis E, Chatzoudi E, Creatsas G. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: a clinical approach. J Matern Fetal Neonatal Med 2003;14:170–176.
  • Li W, Challis JR. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. J Clin Endocrinol Metab 2005;90:6569–6574.
  • Vadillo-Ortega F, Estrada-Gutierrez G. Role of matrix metalloproteinases in preterm labour. BJOG 2005;112(Suppl 1):19–22.
  • Yonemoto H, Young CB, Ross JT, Guilbert LL, Fairclough RJ, Olson DM. Changes in matrix metalloproteinase (MMP)- 2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor. Placenta 2006;27:669–677.
  • Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, Spong CY, Peaceman AM, Leveno KJ, Harper M, Caritis SN, Miodovnik M, Mercer BM, Thorp JM, O'Sullivan MJ, Ramin SM, Carpenter MW, Rouse DJ, Sibai B. Maternal serum interleukin-6, c-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol 2010;Mar 1: [Epub ahead of print].
  • Campbell S, Rowe J, Jackson CJ, Gallery ED. In vitro migration of cytotrophoblasts through a decidual endothelial cell monolayer: the role of matrix metalloproteinases. Placenta 2003;24:306–315.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.